Wed Apr 23 17:11:34 SGT 2014  
SINGAPORE
STD™
    STD genital warts, Singapore (SG)
HIV STD TESTING TREATMENT™
Within 3 days after unprotected sex, stop HIV infection with Post-Exposure Prophylaxis treatment 10 days after unprotected sex, detect HIV infection with the DNA test 28 days after unprotected sex, accurately detect HIV infection with the 20 minute rapid test
Full & comprehensive sexually transmitted disease testing
Males: do not urinate for at least 4 hours before arriving
Females: testing is more accurate when you are not menstruating

STD genital warts, Singapore (SG) | HIV STD TESTING TREATMENT™

Summary

STD genital warts, Singapore (SG) | HIV STD TESTING TREATMENT™ @singaporestd_com: Genital warts (condyloma, condylomata acuminata, venereal wart, anal wart, anogenital wart, "cauliflower" sex disease) screening/diagnosis, testing/check treatment/removal/cure, Singapore. Private and confidential service. Definitions, references, and latest news.

Description

Genital warts: penile warts / vaginal warts / anal warts / anogenital warts / venereal warts / condyloma / condylomata acuminata / "cauliflower" sex disease.

References

Advertisement: Come to sunny Singapore to have your testing and treatment. Singapore Ministry of Health registered general practice (GP) clinic:
SHIM CLINIC
168 Bedok South Avenue 3 #01-473
Singapore 460168
Tel: (+65) 6446 7446
Fax: (+65) 6449 7446
24hr Answering Tel: (+65) 6333 5550
Web: STD genital warts, Singapore (SG)
Opening Hours
Monday to Friday: 9 am to 3 pm, 7 pm to 11 pm
Saturday & Sunday: 7 pm to 11 pm
Public Holidays: Closed
Last registration: one hour before closing time.
Walk-in clinic. Appointments not required.
Bring NRIC, Work Pass or Passport for registration.

Sexual risk (of HIV/STD/pregnancy), and what you can do before and after exposure.

Timeline Event / Available resources
HIV STD Pregnancy
Before exposure
Abstain from sex, Be faithful, or Condom use
Circumcision (males only)
Contraception
(females only)
HIV PrEP (pre-exposure prophylaxis) STD vaccine:
- Hepatitis vaccine
- HPV vaccine
STD / HIV exposure
Unsafe sex / unprotected sex:
No condom / Condom broke / Condom slip
0-72 hours HIV prevention
HIV PEP (post-exposure prophylaxis) treatment
- Stop HIV infection after exposure.
STD testing
If STD symptoms appear, then do STD treatment.
- Males: Do not urinate for at least 4 hours before arriving.
- Females: testing is more accurate when you are not menstruating.
Emergency contraception
(females only)
2 weeks HIV DNA PCR test
1 month 20 minute Alere™ Determine™ Combo HIV rapid test:
- Fingerprick blood sampling.
3 months 20 minute OraQuick® HIV rapid test:
- Oral saliva or
- Fingerprick blood sampling.
Full & comprehensive STD testing
- Males: Do not urinate for at least 4 hours before arriving.
- Females: testing is more accurate when you are not menstruating.

References


Latest News

High‐risk human papillomavirus infection in different histological subtypes of renal cell carcinoma
Wed, 02 Apr 2014 00:00:00 +0100 | Journal of Medical Virology
Limited data exist regarding whether a high‐risk human papillomavirus (HR‐HPV) infection increases the risk of developing renal cell carcinoma. The aim of this study was to investigate whether HPV infection has a role in the pathogenesis or development of a certain histological subtype of renal cell carcinoma. Formalin‐fixed paraffin‐embedded (FFPE) specimens of 122 patients with histopathologically proven renal cell carcinoma and their respective peritumoral tissues were examined. The presence of HPV‐DNA was determined by a combination of MY/GP+ consensus primers and HPV‐16/18 type specific nested PCRs followed by direct sequencing. Catalyzed signal‐amplified colorimetric in situ hybridization (CSAC‐ISH) technique was applied to determine the physical status of viral genom...

Relation between insulin‐like growth factor‐1 receptor and human papilloma virus in patients with oropharyngeal cancer
Wed, 02 Apr 2014 00:00:00 +0100 | Head and Neck
Conclusion. The results suggested that IGF‐1R expression in OPSCC correlated with poor prognosis in HPV‐negative patients. Treatment targeting IGF‐1R could potentially improve the survival of patients with HPV‐negative OPSCC. Head Neck, 2014 (Source: Head and Neck)

Untypable human papillomavirus infection and risk of cervical intraepithelial neoplasia among women with abnormal cervical cytology
Tue, 01 Apr 2014 14:25:09 +0100 | Journal of Medical Virology
The risk of cervical intraepithelial neoplasia and/or invasive cervical cancer associated with untypable human papillomavirus (HPV) infections has been not investigated fully. HPV infection caused by 18 high‐risk and 7 low‐risk genotypes as detected by the INNO‐LIPA genotyping system, was investigated in 4,258 women with abnormal Pap smear referred to a colposcopic service. The prevalence of HPV infection was 76.1%. Rates of cervical intraepithelial neoplasia grade 3+ were 0.88% (9/1,017) in HPV‐negative subjects, 1.8% (7/380) in subjects with untypable HPV infection, 3.2% (11/343) in subjects with single/multiple low‐risk types, 28.3% (201/709) in subjects with multiple low and high‐risk types, 15.2% (162/1,069) in subjects with single high‐risk types, and 31.2% (229/733) in...

UNM professor receives grant for cancer research
Tue, 01 Apr 2014 13:15:01 +0100 | bizjournals.com Health Care:Biotechnology headlines
A University of New Mexico Cancer Center researcher has received a $275,000 grant to study how the human papillomavirus can be used to treat cancers.

‘I don't care whether it's human papillomavirus or ABC, I just want to know if I have cancer.’ Factors influencing women's emotional responses to undergoing human papillomavirus testing in routine management in cervical screening: a qualitative study
Tue, 01 Apr 2014 00:00:00 +0100 | BJOG: An International Journal of Obstetrics and Gynaecology
ConclusionsThese qualitative data suggest that in the context of follow up of abnormal cytology or treatment for CIN, the emotional impact of HPV testing may be modest: women's primary concerns at this time relate to abnormal cytology/CIN. (Source: BJOG: An International Journal of Obstetrics and Gynaecology)

The frequency of herpes simplex virus changes in anal pap smear and its association with squamous intraepithelial lesions in high‐risk male patients
Tue, 01 Apr 2014 00:00:00 +0100 | Diagnostic Cytopathology
This study evaluates the frequency of HSV changes in anal Pap smears and its association with ASILs in a high‐risk population. A computerized search for specimens associated with anal cytology that had positive findings of HSV was performed. The electronic medical records were examined for past diagnosis of herpes, HSV serology prior to or after cytology, and if the patient received treatment after cytologic diagnosis of HSV. Of the 470 anal Pap smears (Thin‐prep) examined, seven had cellular changes consistent with HSV infection. All patients were asymptomatic human immunodeficiency virus (HIV) positive males with no prior HSV serology tests. Two patients had prior diagnoses of HSV infection. Cytologic abnormalities were identified in 86% ranging from atypical squamous cells of undete...

Global Health: Expansion in Use Of Cancer Vaccine
Mon, 31 Mar 2014 20:41:19 +0100 | NYT
More than 80 percent of girls in the Americas now have access to immunization, and in the United States, infections have already dropped significantly.     (Source: NYT)

More than just a test result: molecular screening of human papilloma virus for contemporary management of cervical cancer risk.
Mon, 31 Mar 2014 13:40:02 +0100 | Clinical Laboratory Science : Journal of the American Society for Medical Technology
Authors: McGowin CL, Rohde RE, Redwine G

In Vivo Imaging of Inducible HPV Oral Tumors
Mon, 31 Mar 2014 00:00:00 +0100 | Cancer Research
The treatment paradigms for head and neck squamous cell cancer (HNSCC) are changing due to the emergence of human papillomavirus (HPV)-associated tumors possessing distinct molecular profiles and responses to therapy. Although patients with HNSCCs are often treated with radiotherapy, preclinical models are limited by the ability to deliver precise radiation to orthotopic tumors and to monitor treatment responses accordingly. To better model this clinical scenario, we developed a novel autochthonous HPV-positive oral tumor model to track responses to small molecules and image-guided radiation. We used a tamoxifen-regulated Cre recombinase system to conditionally express the HPV oncogenes E6 and E7 as well as a luciferase reporter (iHPV-Luc) in the epithelial cells of transgenic mice. In the...

A case of a patient with stage III familial hidradenitis suppurativa treated with 3 courses of infliximab and died of metastatic squamous cell carcinoma.
Fri, 28 Mar 2014 00:35:03 +0100 | Dermatol Online J
Authors: Scheinfeld N